SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-003033
Filing Date
2018-03-09
Accepted
2018-03-09 16:55:08
Documents
3
Period of Report
2018-03-09
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K 2017 EARNINGS RELEASE a2017q4-earningsrelease.htm 8-K 28733
2 EXHIBIT 99.1 2017 Q4 EARNINGS RELEASE a2017q4exhibit991earningsr.htm EX-99.1 388577
3 cumberlandpharmalogoa01.jpg GRAPHIC 37721
  Complete submission text file 0001628280-18-003033.txt   470428
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 18680809
SIC: 2834 Pharmaceutical Preparations